BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 18480696)

  • 21. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
    Henderson DC; Cagliero E; Gray C; Nasrallah RA; Hayden DL; Schoenfeld DA; Goff DC
    Am J Psychiatry; 2000 Jun; 157(6):975-81. PubMed ID: 10831479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice.
    Tovey E; Rampes H; Livingstone C
    J Psychopharmacol; 2005 Mar; 19(2):207-10. PubMed ID: 15728442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine: diabetes mellitus, weight gain, and lipid abnormalities.
    Henderson DC
    J Clin Psychiatry; 2001; 62 Suppl 23():39-44. PubMed ID: 11603884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment with clozapine at higher doses after clozapine-induced priapism.
    de Nesnera A
    J Clin Psychiatry; 2003 Nov; 64(11):1394-5. PubMed ID: 14658959
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diabetes in treatment with antipsychotic drugs: who is at risk]].
    Deuschle M
    MMW Fortschr Med; 2005 Dec; 147(51-52):34. PubMed ID: 16402705
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug usage to alleviate the adverse effects of clozapine.
    McKean A; Vella-Brincat J
    Australas Psychiatry; 2011 Apr; 19(2):175. PubMed ID: 21443398
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of lipid management in diabetes.
    Ganda OP
    Cardiol Clin; 2005 May; 23(2):153-64, vi. PubMed ID: 15694744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clozapine use in a forensic population in a New South Wales prison hospital.
    Martin A; O'Driscoll C; Samuels A
    Aust N Z J Psychiatry; 2008 Feb; 42(2):141-6. PubMed ID: 18197509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial dysbetalipoproteinemia: a potentially fatal disorder.
    Bari AU; Hashim R; Rahman SB; Hussain M
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):506-8. PubMed ID: 18798589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection-associated clozapine toxicity.
    Darling P; Huthwaite MA
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):159-60. PubMed ID: 21983501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyslipidemia and atypical antipsychotic drugs.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 18():27-35. PubMed ID: 15600382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine-withdrawal catatonia.
    Bastiampillai T; Forooziya F; Dhillon R
    Aust N Z J Psychiatry; 2009 Mar; 43(3):283-4. PubMed ID: 19230235
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of obesity, lipid and glucose abnormalities in outpatients prescribed clozapine.
    Leonard P; Halley A; Browne S
    Ir Med J; 2002 Apr; 95(4):119-20. PubMed ID: 12090443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should lipids be monitored during the first year of treatment with an atypical antipsychotic?
    Landry P; Benaliouad F
    Can J Psychiatry; 2003 Jun; 48(5):348-9. PubMed ID: 12866344
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased cortical inhibition in persons with schizophrenia treated with clozapine.
    Daskalakis ZJ; Christensen BK; Fitzgerald PB; Moller B; Fountain SI; Chen R
    J Psychopharmacol; 2008 Mar; 22(2):203-9. PubMed ID: 18308816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine-associated pancreatitis.
    Cerulli TR
    Harv Rev Psychiatry; 1999; 7(1):61-3. PubMed ID: 10439307
    [No Abstract]   [Full Text] [Related]  

  • 37. Continuation of clozapine following mild myocarditis.
    Ronaldson KJ; Fitzgerald PB; Taylor AJ; McNeil JJ
    Aust N Z J Psychiatry; 2012 Sep; 46(9):910-1. PubMed ID: 22956573
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
    Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of a potent and selective peroxisome proliferator activated receptor alpha agonist in subjects with dyslipidemia and type 2 diabetes mellitus.
    Terra SG; Francone OL; Contant CF; Gao X; Lewin AJ; Nguyen TT
    Am J Cardiol; 2008 Aug; 102(4):434-9. PubMed ID: 18678301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders.
    de Haan L; Linszen DH; Gorsira R
    J Clin Psychiatry; 1999 Jun; 60(6):364-5. PubMed ID: 10401913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.